These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23881657)

  • 61. Calcium channel blockers for antipsychotic-induced tardive dyskinesia.
    Essali A; Soares-Weiser K; Bergman H; Adams CE
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000206. PubMed ID: 29578611
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.
    Kishimoto T; Hagi K; Kurokawa S; Kane JM; Correll CU
    Lancet Psychiatry; 2021 May; 8(5):387-404. PubMed ID: 33862018
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fluphenazine (oral) versus placebo for schizophrenia.
    Matar HE; Almerie MQ; Sampson S
    Cochrane Database Syst Rev; 2013 Jul; 7(7):CD006352. PubMed ID: 23861067
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Olanzapine for schizophrenia.
    Duggan L; Fenton M; Rathbone J; Dardennes R; El-Dosoky A; Indran S
    Cochrane Database Syst Rev; 2005 Apr; (2):CD001359. PubMed ID: 15846619
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nidotherapy for people with schizophrenia.
    Chamberlain IJ; Sampson S
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD009929. PubMed ID: 23543583
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aripiprazole versus typical antipsychotic drugs for schizophrenia.
    Bhattacharjee J; El-Sayeh HG
    Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD006617. PubMed ID: 18646161
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Electroconvulsive therapy for schizophrenia.
    Tharyan P; Adams CE
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000076. PubMed ID: 15846598
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
    Tardy M; Dold M; Engel RR; Leucht S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009396. PubMed ID: 25003310
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risperidone versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Schwarz S; Schmid F; Hunger H; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006626. PubMed ID: 21249678
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis.
    Gillies D; Beck A; McCloud A; Rathbone J; Gillies D
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003079. PubMed ID: 16235313
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aripiprazole versus placebo for schizophrenia.
    Belgamwar RB; El-Sayeh HG
    Cochrane Database Syst Rev; 2011 Aug; (8):CD006622. PubMed ID: 21833956
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Brooke-Powney MJ; Li X; Adams CE
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009377. PubMed ID: 28758203
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Benzodiazepines for neuroleptic-induced tardive dyskinesia.
    Umbrich P; Soares KV
    Cochrane Database Syst Rev; 2003; (2):CD000205. PubMed ID: 12804389
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia.
    Soares-Weiser KV; Joy C
    Cochrane Database Syst Rev; 2003; (2):CD000208. PubMed ID: 12804390
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increasing antipsychotic dose for non response in schizophrenia.
    Samara MT; Klupp E; Helfer B; Rothe PH; Schneider-Thoma J; Leucht S
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011883. PubMed ID: 29750432
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cholinergic medication for antipsychotic-induced tardive dyskinesia.
    Tammenmaa-Aho I; Asher R; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000207. PubMed ID: 29553158
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Music therapy for people with schizophrenia and schizophrenia-like disorders.
    Geretsegger M; Mössler KA; Bieleninik Ł; Chen XJ; Heldal TO; Gold C
    Cochrane Database Syst Rev; 2017 May; 5(5):CD004025. PubMed ID: 28553702
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia.
    Bighelli I; Rodolico A; Siafis S; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014383. PubMed ID: 36042158
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Maintenance Treatment With Antipsychotic Drugs in Schizophrenia: A Cochrane Systematic Review and Meta-analysis.
    Ceraso A; Lin JJ; Schneider-Thoma J; Siafis S; Heres S; Kissling W; Davis JM; Leucht S
    Schizophr Bull; 2022 Jun; 48(4):738-740. PubMed ID: 35556140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.